Friday, December 20, 2013

Abrams Royal compounding pharmacy recalls all sterile products after adverse event, FDA reports: Food and Drug recalls

CLEVELAND, Ohio-- Abrams Royal Compounding Pharmacy, a Dallas-based pharmaceutical product supplier, is recalling all of its unexpired sterile products after an adverse event related to their use, according to a Food and Drug Administration news release.

The products include injectable medications, IVs, eye drops, pellet implants, nasal sprays, inhalation solutions and eye ointments, and were shipped nationwide to health care facilities, physicians and patients from June 17 to Dec. 17.
The company is recalling the products because a patient in California who received a compounded medication from the pharmacy had an adverse event, according to the FDA. In August, the FDA recalled all sterile products from another Dallas compounding pharmacy, Apoth├ęCure, Inc., after 15 people in two Texas hospitals became ill with bacterial bloodstream infections.

No comments:

Post a Comment